Efficacy and safety of analgesic-eluting urethral catheter after urologic surgery
- Conditions
- Diseases of the genitourinary system
- Registration Number
- KCT0008598
- Lead Sponsor
- Hallym University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Patients scheduled to undergo catheterization due to the need for catheterization after urologic surgery
- Active enough to perform normal activities of daily living (Eastern Cooperative Oncology Group performance status of 0 or 1)
- Patients able to read and give informed consent
- At least 19 years of age and less than 80 years of age
- Prior treatment for urinary system disease, such as radiation therapy, chemotherapy, or hormonal therapy prior to surgery or planned after surgery
- Previous surgery or radiation therapy in the pelvic cavity
- Allergic to pain medications
- Patients with severe hypertension
- Are pregnant
- Do not want to participate in this study voluntarily
- Anyone who, in the opinion of the investigator, is unsuitable for participation in the study
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in urethral pain level from pre-catheterization to 1 day post-catheterization
- Secondary Outcome Measures
Name Time Method evel of discomfort with the use of postoperative analgesic eluting catheters in each group;For each group, the extent to which, at the time of catheter removal, if the catheter were to be reused in the future, they would prefer to use analgesic eluting catheter rather than a generic one.;Level of lower urinary tract symptoms before and after surgery in each group